United States · Who invested in BioNumerik Pharmaceuticals?
BioNumerik Pharmaceuticals's investors include Takeda Pharmaceutical.
2006200820102012
$52MGrowth$1.1MVenture$10MVentureUnited States · Venture startup
Who invested in BioNumerik Pharmaceuticals
3 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$63Mraised across 3 rounds since 2004, from 3 sources
$52MGrowth$1.1MVenture$10MVenture
- Latest round
- Venture, $10MNov 2012
- Biggest round
- $52MGrowth · Oct 2004
- Step-upi
- 9×
- Investors
- 1
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Growth, $52M Oct 2004
- Biggest round
- $52M Growth · Oct 2004
- Usual gap between rounds
- 6.1 years the median of 2
The rounds
- Nov 2012Venture$10M
No investor was named in the report.
Reported by sec.govSEC filing: $10M sold, first sale Oct 2012
- Nov 2010Venture$1.1M
No investor was named in the report.
From a historical funding recordSEC filing: $1.1M sold, first sale Oct 2010
- Oct 2004
Quick answers about BioNumerik Pharmaceuticals
How much has BioNumerik Pharmaceuticals raised?
BioNumerik Pharmaceuticals has raised $63M across 3 rounds since 2004.
When did BioNumerik Pharmaceuticals last raise?
BioNumerik Pharmaceuticals's most recent round was a Venture of $10M in Nov 2012.
What was BioNumerik Pharmaceuticals's biggest round?
BioNumerik Pharmaceuticals's largest round on record is $52M (Growth), in Oct 2004.
Who backed BioNumerik Pharmaceuticals first?
BioNumerik Pharmaceuticals's first round on record, in Oct 2004, was backed by Takeda Pharmaceutical.
What stage is BioNumerik Pharmaceuticals at?
BioNumerik Pharmaceuticals's latest named round is a Venture, in Nov 2012.
Where is BioNumerik Pharmaceuticals based?
BioNumerik Pharmaceuticals is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.